| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer
1 company
Wentworth Kory James is a Chief Financial Officer at TRDA. Recent filings cover 0 purchases and 37 sales. Those positions are worth an estimated $838K at current prices.
Our model assigns Wentworth Kory James a middling insider score of 61/100, based on 28 past trades. Over a 12-month horizon, 48.1% of those trades were profitable, with an average 12-month return of +6.4%.
Wentworth Kory James's largest disclosed position is in TRDA as Chief Financial Officer, worth about $838K. The recent filings there lean toward selling, a net 128,816 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 18, 2022 | TRDA Entrada Therapeutics, Inc. | Chief Financial Officer | Sale+OE | 600 | $13.02 | $7,814.00 | -2.9% | +35.2% | +22.1% |